全球整容手术市场:市场规模、区域前景、竞争策略以及按性别、手术、年龄层、提供者和最终用户分類的细分市场预测(截至 2033 年)
市场调查报告书
商品编码
1421520

全球整容手术市场:市场规模、区域前景、竞争策略以及按性别、手术、年龄层、提供者和最终用户分類的细分市场预测(截至 2033 年)

Cosmetic Surgery Market Size- By Gender, By Procedure, By Age Group, By Provider, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 255 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计2033年,整容手术市场规模将达到650.8亿美元,复合年增长率为4.11%。

本报告调查了全球整容手术市场,并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争形势、主要企业简介等。总结。

目录

第一章简介

第二章调查方法

第三章执行摘要

第四章市场动态

  • 驱动因素、限制因素、机会与挑战分析
  • COVID-19 对市场的影响

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争形势

  • 製造地、销售区域、产品类型分布
  • 併购、联盟、产品发布、合作

第七章全球整容市场:性别

  • 全球市占率及预测
  • 女士
  • 男性

第八章全球整容手术市场:依程序分类

  • 全球市占率及预测
  • 非手术治疗
  • 手术过程

第九章全球整容手术市场:依年龄组别

  • 全球市占率及预测
  • 18岁以下
  • 19-34岁
  • 35-50岁
  • 51-64岁
  • 65岁以上

第十章全球整容手术市场:依供应商分类

  • 全球市占率及预测
  • 医院/专科诊所
  • 水疗/美容手术中心

第十一章全球整容手术市场预测

  • 市场规模/市场占有率

第十二章全球整容手术市场:性别

  • 市场规模/市场占有率趋势/预测

第十三章全球整容手术市场:依程序分类

  • 市场规模/市场占有率趋势/预测

第14章全球整容手术市场:依年龄组别

  • 市场规模/市场占有率趋势/预测

第十五章全球整容手术市场:依供应商分类

  • 市场规模/市场占有率趋势/预测

第十六章全球整容手术市场:按地区

  • 市场规模/市场占有率趋势/预测
  • 亚太地区
  • 欧洲
  • 中东/非洲
  • 北美洲
  • 拉丁美洲

第十七章 公司简介

  • AbbVie Inc.
  • Apyx Medical
  • Bausch Health Companies Inc.
  • Cutera
  • Cynosure
  • GALDERMA
  • Johnson & Johnson Services, Inc.
  • Long Island Plastic Surgical Group, PC
  • Merz Pharma
  • Sientra Inc.
  • 其他的

第十八章简称表

第十九章 参考链接

第20章结论

第二十一章 研究范围

简介目录
Product Code: FMCG2415

Introduction and Overview

According to SPER market research, 'Cosmetic Surgery Market Size- By Gender, By Procedure, By Age Group, By Provider- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Cosmetic Surgery Market is predicted to reach USD 65.08 billion by 2033 with a CAGR of 4.11%.

The purpose of cosmetic plastic surgery is to alter your appearance. For some, this could entail reshaping the body, removing bald spots, or smoothing out wrinkles. Others might decide for breast augmentation or treatment for varicose veins. The procedure is elective and performed more for aesthetic than for medicinal purposes. Men and women can pick from a variety of cosmetic surgery procedures to create an image that increases their sense of self-assurance and comfort with their looks.

Because of the lockdown and travel restrictions brought on by the COVID-19 pandemic, which hindered hospital and clinic patient chains, the global market for cosmetic surgery was significantly impacted. In order to reduce the possibility of cross-contamination among patients and medical personnel, the health care facilities chose to perform emergency and major*surgeries. Additionally, it restricted people's discretionary cash, which had an immediate effect on the demand for cosmetic surgery.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2033
  • Base year considered: 2022
  • Forecast period: 2023-2033
  • Segments covered: By Gender, By Procedure, By Age Group, By Provider.
  • Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
  • Companies Covered: AbbVie Inc., Apyx Medical, Bausch Health Companies Inc., Cutera, Cynosure, GALDERMA, Johnson & Johnson Services, Inc., Long Island Plastic Surgical Group, PC, Merz Pharma, Sientra, Inc.

Market Segmentation

  • By Gender: Based on the Gender, Global Cosmetic Surgery Market is segmented as; Female, Male.
  • By Procedure: Based on the Procedure, Global Cosmetic Surgery Market is segmented as; Non-Surgical Procedure, Surgical Procedure.
  • By Age Group: Based on the Age Group, Global Cosmetic Surgery Market is segmented as; 18 Years and Younger, 19 to 34 Years, 35 to 50 Years, 51 to 64 Years, 65 Years & Above.
  • By Provider: Based on the Provider, Global Cosmetic Surgery Market is segmented as; Hospitals & Speciality Clinics, Spas & Cosmetic Surgery Centres.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts on the Global Cosmetic Surgery Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Cosmetic Surgery Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cosmetic Surgery Market

7. Global Cosmetic Surgery Market, By Gender (USD Million)

  • 7.1. Global Cosmetic Surgery Market Value Share and Forecast, By Gender, 2023-2033
  • 7.2. Female
  • 7.3. Male

8. Global Cosmetic Surgery Market, By Procedure (USD Million)

  • 8.1. Global Cosmetic Surgery Market Value Share and Forecast, By Procedure, 2023-2033
  • 8.2. Non-Surgical Procedure
  • 8.3. Surgical Procedure

9. Global Cosmetic Surgery Market, By Age Group (USD Million)

  • 9.1. Global Cosmetic Surgery Market Value Share and Forecast, By Age Group, 2023-2033
  • 9.2. 18 Years and Younger
  • 9.3. 19 to 34 Years
  • 9.4. 35 to 50 Years
  • 9.5. 51 to 64 Years
  • 9.6. 65 Years & Above

10. Global Cosmetic Surgery Market, By Provider (USD Million)

  • 10.1. Global Cosmetic Surgery Market Value Share and Forecast, By Provider, 2023-2033
  • 10.2. Hospitals & Speciality Clinics
  • 10.3. Spas & Cosmetic Surgery Centres

11. Global Cosmetic Surgery Market Forecast, 2019-2033 (USD Million)

  • 11.1. Global Cosmetic Surgery Market Size and Market Share

12. Global Cosmetic Surgery Market, By Gender 2019-2033 (USD Million)

  • 12.1. Global Cosmetic Surgery Market Size and Market Share by Gender (2019-2026)
  • 12.2. Global Cosmetic Surgery Market Size and Market Share by Gender (2027-2033)

13. Global Cosmetic Surgery Market, By Procedure, 2019-2033 (USD Million)

  • 13.1. Global Cosmetic Surgery Market Size and Market Share by Procedure (2019-2026)
  • 13.2. Global Cosmetic Surgery Market Size and Market Share by Procedure (2027-2033)

14. Global Cosmetic Surgery Market, By Age Group, 2019-2033 (USD Million)

  • 14.1. Global Cosmetic Surgery Market Size and Market Share by Age Group (2019-2026)
  • 14.2. Global Cosmetic Surgery Market Size and Market Share by Age Group (2027-2033)

15. Global Cosmetic Surgery Market, By Provider, 2019-2033 (USD Million)

  • 15.1. Global Cosmetic Surgery Market Size and Market Share by Provider (2019-2026)
  • 15.2. Global Cosmetic Surgery Market Size and Market Share by Provider (2027-2033)

16. Global Cosmetic Surgery Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Cosmetic Surgery Market Size and Market Share by Region (2019-2026)
  • 16.2. Global Cosmetic Surgery Market Size and Market Share by Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. AbbVie Inc.
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Apyx Medical
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Bausch Health Companies Inc.
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Cutera
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Cynosure
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. GALDERMA
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Johnson & Johnson Services, Inc.
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Long Island Plastic Surgical Group, PC
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Merz Pharma
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Sientra Inc.
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope